B-cell activating factor

Revision as of 14:01, 23 September 2007 by (talk)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
tumor necrosis factor (ligand) superfamily, member 13b
Alt. symbolsTNFSF20
Other data
LocusChr. 13 q32-34

B-cell activating factor (BAFF) is the Tumor necrosis factor ligand superfamily member 13B (TNFLSF13B), also known as B Lymphocyte Stimulator (BLyS) and TNF- and APOL-related leukocyte expressed ligand (TALL-1) and the Dendritic cell-derived TNF-like molecule (CD257 antigen). BAFF is a 285-amino acid long peptide glycoprotein which undergoes glycosylation at site #124. It is expressed as transmembrane protein on different cells, such as monocytes, dendritic cells and bone marrow stromal cells. The transmembrane form can be cleaved from the membrane, generating a soluble protein fragment. BAFF is the natural ligand of three unusual Tumor Necrosis Family Receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called A Proliferation Inducing Ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling trough BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors [1].


  1. Oren,D.A., Li,Y., Volovik,Y., Morris,T.S., Dharia,C., Das,K., Galperina,O., Gentz,R. and Arnold,E. (2002). "Structural basis of BLyS receptor recognition". Nat. Struct. Biol. 9: 288–292. PMID 11862220.

External links